English
Zydus Lifesciences Q3 Results
- BSE: 532321
- NSE: ZYDUSLIFE
- ISIN: INE010B01027
- Sector: Biotechnology & Drugs
BSE
928.35
5.90 (0.64%)
5.90 (0.64%)Volume9.05 K
Updated: Fri 12 Dec, 2025 | 15:29:36
NSE
929.156.60 (0.72%)
6.60 (0.72%)Volume4.35 L
Updated: Fri 12 Dec, 2025 | 15:53:09
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Zydus Lifesciences Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 4,293.10 | 4,054.60 | 5.88% | 3,618.20 | 18.65% |
| Depreciation/ Amortization | 229.00 | 233.60 | -1.97% | 194.80 | 17.56% |
| Operating Income | 976.00 | 1,182.40 | -17.46% | 887.00 | 10.03% |
| Net Income | 1,023.50 | 911.20 | 12.32% | 789.60 | 29.62% |
| Other Operating Expenses Total | 1,534.20 | 1,470.40 | 4.34% | 1,137.60 | 34.86% |
| Net Income Before Taxes | 1,184.10 | 1,270.90 | -6.83% | 925.50 | 27.94% |
| Total Revenue | 5,269.10 | 5,237.00 | 0.61% | 4,505.20 | 16.96% |
| Selling/ General/ Admin Expenses Total | 946.50 | 879.20 | 7.65% | 817.30 | 15.81% |
| Diluted Normalized EPS | 10.17 | 9.06 | 12.32% | 7.58 | 34.13% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.